image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
SC 13G/A
Filing Date
February 09, 2023
Document Date
February 09, 2023
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC
Print Page
RSS Feeds
Email Alerts
Search